If you or a loved one has recently taken an over-the-counter or prescription drug and subsequently developed Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis, you may have legal recourse against the drug manufacturer. Please contact one of our attorneys to see how we can protect your rights.
Stevens-Johnson Syndrome, or SJS, is a rare but extremely severe rash that can travel through the mucous membranes in the body and is often deadly. Stevens-Johnson Syndrome is a catastrophic and often fatal adverse reaction that is described colloquially as the body burning itself from the inside out. In more severe forms, the skin peels off in sheets from vast parts of the body, similar to the effects of a third-degree burn injury.
SJS is typically characterized by severe inflammation of a patient’s mucous membranes surrounding their mouth, throat, eyes, and genital areas, resulting in painful blisters and lesions that spread to other areas of the body. Abnormalities and injuries to the eyes often occur.
Stevens-Johnson Syndrome is an auto-immune, debilitative disorder of the skin and mucous membranes and is usually caused by adverse reaction or allergy to an over-the-counter or prescription drug.
Stevens-Johnson Syndrome is sometimes referred to by a subset of names, including:
Symptoms of SJS usually begin with a fever and sore throat, accompanied by blistering, lesions, and ulcers on the mouth, lips, and in the genital area. Symptoms and adverse events associated with SJS include:
SJS symptoms are also found in patients who suffer from Toxic Epidermal Necrolysis (TEN), a similarly life-threatening rash that leads to the top layer of skin to blister and peel off in large sheets. SJS and TEN are different names for similar diseases. SJS involves 10% of the skin or less, and the risk of death is 5-15%. In comparison, TEN affects over 30% of the skin, and at least one-third of patients die. Both Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis are life-threatening medical emergencies that require immediate medical attention and hospitalization. Approximately 2 million Americans are diagnosed with these conditions each year. Many survivors suffer disability, blindness, or disfigurement. In both diseases, patients endure pain so horrific that hospitals often place them in medical comas.
Although SJS and TEN can impact anyone, those who have compromised or underdeveloped immune systems (such as HIV or lupus patients, the elderly population, and children) are most at risk.
There are more than 200 medications that may be linked to Stevens-Johnson Syndrome, or SJS. SJS may be a life-threatening reaction, typically caused by over-the-counter drugs and prescription drugs. The drugs most commonly associated with SJS/TEN include:
Some drug manufacturers fail to include adequate warnings on their drugs’ prescribing labels, boxes or package inserts, such that the risk of SJS is not adequately communicated or explained. These inadequate warnings result in the continued prescription and use of over-the-counter and prescription drugs that result in SJS and TEN.
There may be many possible complications or comorbidities that coincide with an SJS/TEN diagnosis, including varying symptoms. First, the severe adverse skin reaction can lead to a life-threatening infection, such as meningitis (an infection of the membrane and fluid that encase the brain and the spinal cord) or sepsis (an infection of the entire body). These infections occur when bacteria enters the bloodstream and travels throughout the body, often leading to shock and failure of vital organs.
Patients diagnosed with SJS or TEN also experience permanent, severe eye problems, damage to organs, and skin damage.
In 2005, the U.S. Food and Drug Administration (FDA) issued a recommendation that all drug and pharmaceutical manufactures of non-steroidal anti-inflammatory drugs (NSAIDs) such as Children’s Motrin, ibuprofen and Celebrex include warnings in their drug literature to adequately inform patients of the risk of Stevens-Johnson Syndrome or TEN associated with the use of their products.
In 2013, the FDA issued a Safety Communication warning that acetaminophen, found in the ubiquitous fever and pain reliever Tylenol, may cause Stevens-Johnson Syndrome and TEN. After conducting research into over 100 cases of severe skin rash following the use of Tylenol in patients from 1969-2012, the FDA found that sufficient evidence linked the use of the acetaminophen and the adverse symptoms attributed to SJS. The FDA required that prescription drug labels warn about the potential for SJS symptoms after using Tylenol and other acetaminophen drugs within approximately 28 days after the onset of use.
Lamictal, also known by its generic name Lamotrigine, is an anti-convulsant epilepsy drug used to treat symptoms of epilepsy and bipolar disorder, but studies show a strong link between use of Lamictal and adverse events such as severe rashes and Stevens-Johnson Syndrome. Lamictal side effects have been added to the drug’s labeling in a Black Box Warning as far back as March 1997.
The FDA required the addition of a Black Box Warning, the administration’s strongest warning, on Lamictal’s label in 2015 to warn users about potentially life-threatening and fatal cases of SJS and TEN from Lamictal use. The Black Box Warning states that it is critically essential for Lamictal users to look for any signs of a rash on their bodies and to seek immediate medical treatment should a rash develop.
If you or a loved one exhibits signs or symptoms of Stevens-Johnson Syndrome or TEN, it is imperative that you seek medical treatment immediately and cease use of any medication linked to the contraction of SJS or TEN.
If you or a loved one has developed SJS or TEN after taking an over-the-counter or prescription medication such as those listed above, we want to help. Please contact our attorneys for a consultation on your legal rights.
Fill out this form for a FREE, immediate, Case Evaluation
Please read these Terms and Conditions ("Terms", "Terms and Conditions") carefully before using the https://www.kbaattorneys.com/ website (the "Service") operated by KBA Attorneys ("us", "we", or "our").
Your access to and use of the Service is conditioned on your acceptance of and compliance with these Terms. These Terms apply to all visitors, users and others who access or use the Service.
By accessing or using the Service you agree to be bound by these Terms. If you disagree with any part of the terms then you may not access the Service. The materials contained in this web site are protected by applicable copyright and trade mark law.
The materials and information contained within the Service is of a general, informational nature but does not constitute legal or professional advice and should not be constituted as such. Use of the Service in any way, does not establish an attorney-client relationship.
Except as required by law, neither KBA Attorneys nor its affiliated firms or businesses accept any responsibility and shall not be liable for any damages (direct, indirect, incidental, special, consequential or exemplary), resulting from the use of this Service. This includes, but is not limited to, damages (for loss of profits, goodwill, use, data or other intangible losses) resulting from the use of or inability to use the Service or its contents or from any interruption or delay in access to the Service for whatever reason.
Note also that sending an e-mail to our office does not create a lawyer-client relationship, and none will be formed unless there is an expressed agreement between the firm and the client. Therefore, we strongly advise you against sending confidential or privileged information to us until you can establish such a relationship.
Our Service may contain links to third-party websites or services that are not owned or controlled by KBA Attorneys
KBA Attorneys has no control over, and assumes no responsibility for, the content, privacy policies, or practices of any third party websites or services. You further acknowledge and agree that KBA Attorneys shall not be responsible or liable, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with use of or reliance on any such content, goods or services available on or through any such websites or services.
We strongly advise you to read the terms and conditions and privacy policies of any third-party websites or services that you visit.
These Terms shall be governed and construed in accordance with the laws of Maryland and Virgina, United States, without regard to its conflict of law provisions.
Our failure to enforce any right or provision of these Terms will not be considered a waiver of those rights. If any provision of these Terms is held to be invalid or unenforceable by a court, the remaining provisions of these Terms will remain in effect. These Terms constitute the entire agreement between us regarding our Service, and supersede and replace any prior agreements we might have between us regarding the Service.
We reserve the right, at our sole discretion, to modify or replace these Terms at any time. If a revision is material we will try to provide at least 30 days notice prior to any new terms taking effect. What constitutes a material change will be determined at our sole discretion.
By continuing to access or use our Service after those revisions become effective, you agree to be bound by the revised terms. If you do not agree to the new terms, please stop using the Service.
If you have any questions about these Terms, please contact us.